Kieser Brian Joseph bought NXGL

November 10, 2026 · Form 4 insider transaction

Kieser Brian Joseph bought 1,000,000 shares of NEXGEL, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,000,000
Price
N/A
Total value
N/A
Role—
SecurityConvertible Promissory Note (as amended)
Transaction codeA: Grant or award
Transaction dateNovember 10, 2026
Filing dateNovember 13, 2026
Shares owned after1,000,000
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

On November 10, 2026, the Reporting Person and Sequence entered into Note Amendment and Conversion Agreements with the Issuer that, among other things, reduced the conversion price of each Convertible Promissory Note from $12.00 to $5.50 per share and the exercise price of each Existing Warrant from $16.00 to $13.00 per share. The amendments are reported as the disposition of the original derivative security and the acquisition of the amended derivative security. The original securities are treated as disposed of solely for purposes of this Form 4 reporting; they were amended and remain outstanding as amended. The transactions were approved in advance by the Issuer's Board of Directors on November 10, 2026 for purposes of Rule 16b-3(d) and (e). Share amounts reflect the 1-for-20 reverse stock split effective October 12, 2026. The Note and Existing Warrant held directly were issued on May 11, 2026, and those held by Sequence were issued on April 17, 2026.; The conversion price is subject to reset on the first anniversary of issuance and at maturity. The Note converts at the Issuer's closing of the contemplated merger or earlier at the holder's election, subject to the Exchange Cap.; The securities are held of record by Sequence. The Reporting Person is the indirect sole owner of Sequence and may be deemed to have voting and investment power over the securities held by Sequence. The Reporting Person disclaims beneficial ownership of the securities held by Sequence except to the extent of his pecuniary interest therein.

View the original Form 4 on SEC EDGAR